Related content

Is 3′-deoxy-3′-¹⁸F-fluorothymidine a better marker for tumour response than ¹⁸F-fluorodeoxyglucose?

By Reske Sven   Deisenhofer Sandra  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 1, 2006-07 ,pp. : 38-43

Springer Publishing Company

Access to resources Recommend Favorite

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3′-deoxy-3′-[¹⁸F]fluorothymidine positron emission tomography

By Kenny Laura   Coombes R.   Vigushin David   Al-Nahhas Adil   Shousha Sami   Aboagye Eric  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 9, 2007-09 ,pp. : 1339-1347

Springer Publishing Company

Access to resources Recommend Favorite

A simplified analysis of [F]3′-deoxy-3′-fluorothymidine metabolism and retention

By Shields Anthony   Briston David   Chandupatla Samatha   Douglas Kirk   Lawhorn-Crews Jawana   Collins Jerry   Mangner Thomas   Heilbrun Lance   Muzik Otto  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 32, Iss. 11, 2005-11 ,pp. : 1269-1275

Springer Publishing Company

Access to resources Recommend Favorite

A simplified analysis of [¹⁸F]3′-deoxy-3′-fluorothymidine metabolism and retention

By Shields Anthony   Briston David   Chandupatla Samatha   Douglas Kirk   Lawhorn-Crews Jawana   Collins Jerry   Mangner Thomas   Heilbrun Lance   Muzik Otto  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 4, 2007-04 ,pp. : 613-613

Springer Publishing Company

Access to resources Recommend Favorite

Positron Emission Tomography with [ 18 F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study

By Dehdashti Farrokh  

Molecular Imaging and Biology, Vol. 15, Iss. 1, 2013-02 ,pp. : 106-113

Springer Publishing Company

Access to resources Recommend Favorite